Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1669-1671

  Volm, Manfred ^a   Mattern, Jürgen ^a   Koomägi, Reet ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Apoptosis; Caspase 3; Fas ligand; Microvessel density; Squamous cell lung carcinomas; VEGF

Indexed keywords

CASPASE 3; FAS LIGAND; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANOXIA; APOPTOSIS; CAPILLARIES; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASES; ENDOTHELIAL GROWTH FACTORS; FAS LIGAND PROTEIN; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032782809     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
2. Xerri L, Devilard E, Hassoun J, Haddad P and Birg F: Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Leukemia 11: 1868-1877, 1997.
3. Rowan S and Fisher DE. Mechanisms of apoptotic cell death. Leukemia 11: 457-465, 1997.
4. Jarpe MB, Widmann C, Knall C, Schlesinger TK, Gibson S, Yujiri T, Fanger GR, Gelfand EW and Johnson GL: Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stops signs along the road to death. Oncogene 17: 1475-1482, 1998.
5. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
6. Krajewski S, Zapata JM, Shabaik A, Cascoyne R and Reed JC: Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57: 1605-1613, 1997.
7. Hickman JA: Apoptosis and chemotherapy resistance. Eur J Cancer 6: 921-926, 1996.
8. Friesen, C Herr I, Krammer PH and Debatin KM: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug induced apoptosis in leukemic cells. Nature Med 2: 574-577, 1996.
9. Yao KS, Clayton M and O'Dwyer PJ: Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia. J Natl Cancer Inst 87: 117-121, 1925.
10. Ciacca AJ: Hypoxic stress proteins: survival of the fittest. Sem Rad Oncol 6: 46-58, 1996.
11. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
12. Koomägi R, Mattern J and Volm M: Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis 16: 2129-2133, 1995.
13. Volm M, Koomägi R and Mattern J: Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma. Anticancer Res 16: 213-218, 1996.
14. Mattem J, Kallinowski F, Herfarth C and Volm M: Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 67: 20-23, 1996.
15. Lu C and Tanigawa N: Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res 57: 221-224, 1997.
16. Volm M, Mattern J and Samsel B: Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-π in human lung tumors. Cancer 70: 764-769, 1992.
17. Holgren L, O'Reilly S and Folkman J: Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1: 149-153, 1995.
18. Matsumoto T, Yukita A, Asano M, Suzuki H, Nakamura S and Baba S: Antitumor effect of VEGF neutralizing antibody on the human gastric cancer. Am Ass Cancer Res 39: 44, 1998.
19. Graeber TG, Peterson JF, Tsai M, Monica K, Formace AJ and Giaccia AJ: Hypoxia induces the accumulation of p53 protein, but the activation of a G1-phase checkpoint by low oxygen conditions is independent of p53 status. Mol Cell Biol 14: 6264-6277, 1994.
20. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.